Are Researchers Required to Purchase from the Official SwissChems Website
1 With the growing interest in weight management and metabolic health, GLP-1 supplements have emerged as a promising tool in addressing issues like obesity, diabetes, and even cardiovascular health
The pivotal obesity trials Lilly needs for a commercial label, TRIUMPH-1 and TRIUMPH-3, are still running and read out across 2026
Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
Additionally, semaglutide has been shown to have a comparable risk profile to other GLP-1 RAs with respect to gastrointestinal adverse effects in the IBD population (106)
